Search for: "INVAGEN PHARMACEUTICALS, INC."
Results 1 - 4
of 4
Sorted by Relevance
|
Sort by Date
31 Jul 2011, 9:44 pm
Hetero Drugs Ltd. et al. 1:11-cv-05135; filed July 26, 2011 in the Southern District of New York • Plaintiffs: Pfizer Inc.; Pfizer Ltd.; Pfizer Ireland Pharmaceuticals • Defendants: Hetero Drugs Ltd.; Hetero USA Inc.; Invagen Pharmaceuticals Inc.; Hetero Labs Ltd., Unit V Infringement of U.S. [read post]
17 Jun 2012, 9:55 pm
., Unit III; Invagen Pharmaceuticals, Inc. [read post]
31 May 2021, 7:51 pm
Background The complaint in Shilpa basically alleged that the defendant majority shareholders of InvaGen Pharmaceuticals, Inc., a Long Island-based generic pharmaceutical company, cheated the plaintiff minority shareholder out of $14.3 million in proceeds from the sale of InvaGen to a multinational pharmaceutical company. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Holman’s Biotech IP Blog) US: Myriad writes to CAFC on standing issue (Patent Docs) (Patent Docs) (Holman’s Biotech IP Blog) US: In the first 7 months of 2011, the FDA has approved 18 new molecular entity pharmaceutical drugs (and no biologic NMEs) (KEI) US: Embryonic stem cell funding suit dead: Sherley v. [read post]
